Portman Ridge Finance Corporation - Closed End Fund (PTMN)
16.98
-0.05 (-0.32%)
Portman Ridge Finance Corp is a publicly traded company that specializes in providing capital solutions primarily to the middle-market companies across various industries
The firm engages in making investments in debt and equity securities, focusing on generating attractive risk-adjusted returns for its investors. By targeting businesses that require financing for growth, acquisitions, or refinancing existing debt, Portman Ridge seeks to build a diversified portfolio that complements its investment strategy. Through its expertise in credit markets, the company aims to deliver high-quality investment opportunities while managing risk effectively.
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Portman Ridge Finance Corporation (NASDAQPTMN) and Logan Ridge Finance Corporation is fair to Portman shareholders.
NEW YORK, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (“Portman Ridge”) and Logan Ridge Finance Corporation (Nasdaq: LRFC) (“Logan Ridge”) announced today that their boards of directors have established special committees of independent directors to more fully evaluate the potential business combination of the two companies that was previously disclosed in their respective Form 10-Q filings with the Securities and Exchange Commission (the “SEC”), which may result in the use of an exchange ratio other than NAV-for-NAV (including but not limited to relative market price or a fixed exchange ratio) in connection therewith.
Portman Ridge (NASDAQPTMN) is at the forefront of providing innovative investment solutions and strategic financing. The company will be presenting alongside world-class headliners such as Zack Kass, former Head of Go-To-Market at OpenAI where ChatGPT was created, and “Shark Tank” stars Kevin O’Leary, Robert Herjavec, and Daymond John.
PTMN stock results show that Portman Ridge Finance missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Reports Strong Year-Over-Year Performance with Total Investment Income of $76.3 Million, an Increase of 9.6% and Net Investment Income of $34.8 Million
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQSGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
NEW YORK, NY / ACCESSWIRE / December 5, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day December Small-Cap Conference taking place Wednesday and Thursday, December 6-7, 2023. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Reports Strong Performance with Increases in Net Asset Value Per Share Quarter-over-Quarter, Core Investment Income and Net Investment Income Year-over-Year, While Also Continuing Share Repurchase Program in the Third Quarter of 2023
Reports Strong Performance with Elevated Total Investment Income, Core Investment Income and Net Investment Income Year-over-Year, While Also Continuing Share Repurchase Program in the Second Quarter of 2023
